The waterfall plots displayed the top fifteen mutated genes in both risk groups, and the findings revealed that low-risk HNSCC patients displayed a lower propensity for TP53 mutations than high-risk patients (57% vs. 74%, respectively) (Fig. 11A, B). This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.